Publications by authors named "Yuqi Chu"

We prepared a rhodamine-TEMPO chromophore-radical dyad (RB-TEMPO) to study the radical enhanced intersystem crossing (REISC). The visible light-harvesting chromophore rhodamine is connected with the TEMPO (a nitroxide radical) via a C-N bond. The UV-vis absorption spectrum indicates negligible electron interaction between the two units at the ground state.

View Article and Find Full Text PDF

To improve the aqueous solubility and oral bioavailability of paclitaxel (PTX), a biomimetic system for oral administration of PTX was efficiently developed as an outer membrane vesicle (OMVs) of sodium caseinate (CAS) modified zein nanoparticles (OMVs-Zein-CAS-PTX-NPs) by . To verify their structure and properties, the designed nanostructures were thoroughly characterized using various characterization techniques. The results indicated that hydrogen bonds and van der Waals forces mainly drove the interaction between PTX and Zein, but the complex is unstable.

View Article and Find Full Text PDF
Article Synopsis
  • Increased amounts of dermal mDCs (CD11c cells) were linked to higher itch intensity in prurigo nodularis (PN) skin lesions, as shown through immunofluorescence (IF) studies.
  • These mDCs were found to express IL-31, a cytokine associated with itch, demonstrating a potential role in itch mechanisms.
  • The study also highlighted that mDCs expressing IL-31 mRNA were more prevalent than CD68 macrophages and CD3 T cells in the PN skin lesions, suggesting their significant involvement in itch response.
View Article and Find Full Text PDF

Mastering nuclear fusion, which is an abundant, safe, and environmentally competitive energy, is a great challenge for humanity. Tokamak represents one of the most promising paths toward controlled fusion. Obtaining a high-performance, steady-state, and long-pulse plasma regime remains a critical issue.

View Article and Find Full Text PDF

Background: Interstitial granulomatous dermatitis (IGD) and palisaded neutrophilic granulomatous dermatitis (PNGD) are uncommon presentations of reactive granulomatous dermatitis. Histologic lesions characterized by IGD/PNGD patterns have been associated with systemic diseases, causing an unmet need for revealing clinical correlates.

Objective: The aim of this study was to unravel the systemic diseases beyond dermatitis of IGD/PNGD.

View Article and Find Full Text PDF
Article Synopsis
  • - Pyoderma gangrenosum (PG) is a rare inflammatory skin disorder that leads to quickly forming and painful ulcers.
  • - Palmoplantar pustulosis (PPP) is another inflammatory skin condition characterized by pustules on the hands and feet.
  • - A 68-year-old patient successfully recovered from both PG and PPP after receiving treatment with adalimumab, and the study also reviewed other cases treated with the same medication.
View Article and Find Full Text PDF

Aim: In this study, 5-fluorouracil (5-FU) is delivered to target colon without the interference of mononuclear phagocyte system (MPS).

Methods: Outer membrane vesicles (OMVs) were used as the biological shield to disguise mesoporous silica (MSN) and 5-FU. OMVs-MSN-5-FU were prepared by high pressure co-extrusion, and characterised on the basis of size, drug loading, transmission electron microscope, infra-red spectroscopy, differential scanning calorimetry, thermal gravity analysis, % release, MTT assay, cell uptake and imaging.

View Article and Find Full Text PDF

Recently, biomimetic hybrid drug delivery systems, especially erythrocyte membrane-based drug delivery systems, have been utilized to achieve high bioavailability, and biocompatibility, in the meantime, to reduce immunogenicity and effectively evade phagocytosis of the host immune system. Here, we developed a novel drug delivery system of red blood cell membrane-derived vesicles (RDVs) cloaked poly (acrylic acid)-cystamine hydrochloride-D-α-tocopherol succinate (PAAssVES) nanoparticles. The PAAssVES nanoparticles were prepared via emulsification and solvent volatilization method, followed by loading of the model anti-cancer drug, sorafenib (SFN).

View Article and Find Full Text PDF